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Application of polymerase chain reaction for detection 
of Legionella pneumophila in serum samples 
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A. E Larnbropoulos* and A,  Antoniadis 
'Department of Microbiology, Legionella National Reference Laboratory School of Medicine, 
and 'Department of Biology, School of Medicine, Aristotelian University of Thessaloniki, Greece 
Objective: To apply the polymerase chain reaction (PCR) t o  serum samples for the rapid diagnosis of Legionnaire's 
disease using the L5SL9 and L5SR93 primers designed to generate a 104-base-pair (bp) fragment from the 5s RNA gene 
of Legionella spp. The amplified product was detected by electrophoresis and by hybridization with the L5S-1-specific 
probe. 
Methods: Single specimens of serum obtained from 24 patients with confirmed legionellosis, at different stages of 
their disease, were tested by PCR. Additionally, 10 serum samples from patients with no clinical symptoms of pneumonia 
and 10 samples from patients suffering from pneumonia caused by Mycoplasma pneumoniae, Coxiella burnetii or 
Chlamydia psittaci were also tested as controls in order to determine the specificity of the method. 
Results: Of the 24 examined serum samples, the amplified products from 12 hybridized with the L5S-1 probe 
(sensitivity 50%). None of the negative controls was positive after PCR. No correlation was found between the day of 
illness and the positivity in  the test. 
Conclusions: The PCR technique could be applied as a diagnostic tool for the rapid diagnosis of legionellosis in serum 
samples after modification, mainly to improve its sensitivity. 
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INTRODUCTION 
The rapid diagnosis of legionellosis in the early stages 
of the disease is essential to permit suitable anti- 
inicrobidl chemotherapy, as the disease may be fatal, 
especially in iniiiiunocomproniised patients. The 
conventional diagnostic methods (culture and sero- 
conversion) are time-consuming and may provide only 
retrospective diagnosis. Other methods, such as direct 
iinmunofluorescence (DFA) on Tputuni samples and 
bronchoalveolar lavage or antigen detection i n  urine 
umples  have been applied for this reason [l,2]. 
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The application of P C R  for the detection of 
Lqioriclla przerrriiophiln IINA in sputum samples. 
bronchoalveolar lavage [3-51 and urine sample5 L6.71 is 
very promising for the early diagnosis of the disease. 
Other laboratories have established its sensitivity and 
specificity in coinparison with the isolation of- the 
bacterium by culture 13-51. I n  this study an s th r t  was 
made to apply the PCR technique to serum samples 
obtained from patients suffering from legionellosis. 
This effort was made because J seruiii sample is thc 
iiiost coninion speciiiieii sent by clinicians to the 
laboratory in  atypical pneumonia cases. Although 
bactereniia is not observed in most cases of the disease 
181, the sensitivity ofthe PCR method may allow it to 
detect very small quantities of bacterial I3NA . 
MATERIALS AND METHODS 
Twen ty-four xruiii wiiples from our labor'itorb 
collection were tected bv PCR. Thcse saniples had 
been collected from 21- patients suffering from 
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legionellosis who had been hospitalized in several 
hospitals of northern Greece over the last 5 years. In all 
these cases the diagnosis of the disease was confirmed 
by isolation of the bacteria and/or seroconversion in 
the indirect immunofluorescence test according to 
WHO criteria [9]. In 22 patients the causative agent 
was Legionella pneumophila serogroup 1 and in the other 
two L. pneumophila serogroup 4. In order to cover an 
extended period of the disease and thus to determine 
at which stage of the illness the method would give the 
best results, serum samples obtained on different days, 
between the fifth and the 35th day of the illness, were 
included. They were grouped into three time periods: 
upto the 10th day; from the 11th to the 20th day; and 
from the 21st to the 35th day. 
Ten serum samples with no antibodies against 
L. pneumophila, obtained from patients with no clinical 
symptoms of pneumonia, were tested under the same 
conditions, as negative controls. Another 10 serum 
samples from patients suffering from pneumonia 
caused by Mycoplasma pneumoniae, Coxiella burnetii and 
Chlamydia psittaci were also tested in order to determine 
possible cross-reactions between these microorganisms 
and L. pneumophila. 
DNA was extracted as follows: serum samples were 
thawed and 300 pL of the sample was pipetted into a 
1.5-mL microfuge tube. Fifty microlitres of freshly 
prepared lysozyme solution (10 mg/mL) in 10 mM 
Tris, 1 mM EDTA (pH 8) and 20% sucrose, was added 
and the mixture was incubated at 37°C for 45 min. 
Then 150 pL of 100 mM Tris-HC1, 12.5 mM EDTA, 
150 mM NaC1, 1% sodium dodecyl sulfate (SDS) and 
proteinase K (1 mg/mL) was added. The reactants were 
mixed and incubated at 37°C for 1 h. The mixture was 
extracted with an equal volume of phenol/chloroform 
(50:50). Subsequently, the aqueous phase was removed 
and the DNA was precipitated by the addition of 1/3 
volume of 7.5 M ammonium acetate, and two volumes 
of ice-cold ethanol, with incubation at -20°C for 
30 min. The DNA was collected by centrifugation at 
14000g and the pellets were suspended in 20 pL of 
distilled water. DNA stocks were stored at -20°C until 
use. 
Five microlitres of the DNA suspension was used 
for performance of PCR amplification in a total 
volume of 100 pL of amplification mix, containing 
10 mM Tris-HC1, pH 8.3, 50 mM KC1, 2 mM MgC12, 
0.001% gelatin, 200 m M  of each deoxynucleoside 
triphosphate, 0.65 pM of each primer and 2 units 
of Taq DNA polymerase (Gibco-BRL). P C R  was 
performed using the following protocol: initial de- 
naturation at 95 "C for 10 min followed by 40 cycles of 
denaturation at 95 "C for 30 s, annealing and extension 
at 63°C for 60 s, and final extension at 72°C for 
7 min. The primers used were L5SL9 (5'-ACTA 
TAGCGATTTGGAACCA-3') and L5SR93 (S'- 
GCGATGACCTACTTTCGCAT-3'), which have 
been designed to generate a 104-bp fragment fi-om the 
5 s  R N A  gene of the genus Legionella [lo]. These 
primers were synthesized by GenSet Co. The P C R  
products were electrophoresed on a 1.5% agarose gel 
in TBE buffer (0.089 M Tris, 0.089 M boric acid, 
0.002 M EDTA, pH 8.0), stained with ethidium 
bromide and visualized using a UV transilluminator. 
The lengths of the amplified fragments were estimated 
by comparison with size markers (123-bp DNA Ladder, 
Gibco BRL). 
The P C R  products were transferred onto a 
0.45-pm nitrocellulose membrane according to the 
method of Southern [ l l ] .  The probe L5S-1 (5'- 
CTCGAACTCAGAAGTCAAACATTTCCGCGC 
CAATGATAGTGTGAGCTTC-3'), which hybridized 
to position 40-89 of the legionella rRNA DNA 
sequence [lo], was synthesized and biotinylated by 
GeneSet Co. Membranes were prehybridized at 
42°C for 2 h in hybridization buffer (5xSSC, 50% 
formamide, 0.1% casein, 0.2% SDS) in sealed bags. 
Hybridization was carried out in the same buffer for 
16 h with the addition of 10% dextran sulfate and 
20 ng/mL of the L5S probe. Membranes were then 
washed twice in wash buffer I (2 x SSC, 0.1% SDS) at 
room temperature for 5 min, and then in wash buffer 
I1 (O.lxSSC, 0.1% SDS) twice for 5 min each. The 
detection of the hybridization signal was done with the 
RAD-FREE System (Schleicher and Schuell Co.), 
according to the instructions of the manufacturer. 
Finally, membranes were exposed to Kodak X-OMAT 
films for 15 min. 
Serial dilutions of bacterial DNA suspension 
extracted from cultured L. pneumophila serogroup 1, 
strain Philadelphia 1 (ATCC33152) were tested under 
the same conditions of PCR,  in order to establish 
the lowest detection level. The DNA concentration 
was determined by measuring the optical density at 
260/280 nm. 
From 24 examined serum samples obtained from 
patients with confirmed legionellosis, 12 yielded a 
104-bp P C R  product (Figure lA, lanes 3, 7, 8, 9, 11, 
16 and 17; Figure lB, lanes 3, 4, 6, 7, 8). Additional 
bands are seen on Figure 1. These bands are not 
detected after hybridization on Figure 2, and may 
result from non-specific amplification. After the 
hybridization, the amplified products of 10 of the 
12 serum samples hybridized with the L5S-1 probe 
(Figure 2A, lanes 3, 8, 9, 11, 16 and 17; Figure 2B, 
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Figure 1 Gel electrophoresis of PCR products. L: DNA 
w e  markers with the 123-bp band shown. (A) Lane 1 ,  
PCR product of positive control DNA. Lanes 3, 7, 8, 9, 
1 1, 16 and 17 show the PCK products of patient sera. 
(U) Lane 1, PCR product of negative control. Lanes 3. 1, 6, 
7 and 8 thow the PCK products of patient sera. 
Figure 2 Southern blot hybridization of the amplified 
products with the internal oligonucleotide probe. The 
sequence of the probe is described in the text. (A) Lane 1, 
positive control. Amplified products in lanes 3, 8, 9, 11, 16 
and 17 hybridized with the L5S-l probe. (B) Lane 1, 
negative control. PCR products in lanes 2, 3, 4, 7, 8 and 
I 1  hybridized with the same probe. 
lanes 3, 4, 7 and 8), while the PCR products of two 
serum samples did not hybridize (Figure 2A, lane 7; 
Figure 2B, lane 6). TLVO serum samples whose amplified 
Table 1 Distribution of serum samples according to the 
day of illness, after hybridization of the amplified product 
No. of samples No. of ramples 
Day of No. of positive after negatire after 
illnesr samples hybridlzatlon hybndiza t io~~ 
5-1 0 9 7 1 
11-20 7 3 1 
21-35 8 4 1 
Total 21 12 12 
products could not be detected by electrophoresis 
(Figure lB,  lanes 2 and 11) were positive after hybrid- 
ization (Figure 2B, lanes 2 and 11). All the serum 
samples used as negative controls were negative after 
P C R ,  by both electrophoresis and hybridization tests. 
Table 1 shows the results of the  hybridization in relation 
to the period of the disease during which the sample 
was obtained. After hybridization, five of nine saniplec 
obtained during the acute phase of  the disease were 
positive. From those samples obtained during the 
convalescent phase, three of seven taken from the 1 1 th 
to  the 20th day were positive, and four of eight serum 
samples taken from the 21st to the 30th day were also 
positive. T h e  detection level by PCR was calculated to 
be as low as 125 pg/inL.The sensitivity of PCR was 
determined by detecting the amplified products 
obtained from serial dilutions of extracted legionella 
genomic D N A  by gel electrophoresis. 
DISCUSSION 
T h e  relatively low prevalence of Legionnaires’ disease 
demands a highly sensitive and specific method for the 
detection of the bacterium. T h e  direct diagnosis of 
the disease is particularly important in immuno- 
compromised patients. 
Bacteremia is not a common feature of the disease, 
as L. pneurnoplzila is subjected to  phagocytosis by 
rnonocytes and alveolar macrophages [8] .  T h e  finding 
of legionella antigen in urine, early in the infection, 
suggests that antigenernia must occur presumably as a 
sequel to  phagocytosis [12]. Therefore, the possibility 
of the application of P C R  serum samples for the 
diagnosis of legionellosis seems to be very promising. 
Other  investigators have detected pneumococcal [13], 
mycobacterial [14] and listerial [15] DNA in whole 
blood and buffy coats. 
In this study, an effort has been made to detect 
legionella D N A  in serum samples. There have been 
only two studies previously reported on this subject 
using paired sera 17,121. T h e  serum samples we 
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examined were obtained from different patients with 
confirmed legionellosis on different days of their 
disease. The detection of legionella DNA was 
successful in 12 out of 24 examined patients. Blood 
cultures had not been previously performed in any of 
these patients. Thus no information exists about their 
bacteremic load. Our findings support the view that a 
range of breakdown products including bacterial DNA 
may be present in serum at some stages of the disease 
[12]. The results of our study show that the sensitivity 
of the P C R  technique as a diagnostic method using this 
generic pair of primers is low, even though in control 
experiments under the same conditions we could 
detect bacterial DNA at concentrations as low as 
125 pg/mL. One might expect more positive results in 
the serum samples taken during the acute than in the 
convalescent phase; however, no correlation was 
observed between the period of illness and the positive 
P C R  results. A positive result was obtained in a serum 
sample taken on the 35th day after the onset of the 
disease, probably due to the survival of L. pneumophila 
in the phagocytes and its exit into the circulation at a 
later stage. 
A low sensitivity of PCR in serum samples &om 
patients with a confirmed diagnosis of legionella 
infection has also been reported by other investigators, 
who have found 64% sensitivity while using another 
pair of generic primers [7]. We speculate that the 
reduced sensitivity can be attributed to two major 
factors. The first is the use of a generic pair of primers 
which identifies common DNA in all Legionella spp. 
The use of another pair of primers, for the mip gene of 
L. pneumophila [I21 or for the gene coding the major 
outer-membrane protein [ 161 might provide higher 
sensitivity. Second, many of the patients’ serum samples 
were stored for an extended period, sometimes as long 
as 5 years, and the samples were subjected to many 
rounds of thawing and freezing. This may have allowed 
the introduction of DNases. In addition, various factors 
attributable to the patient may affect the sensitivity of 
the PCR. For instance, severe infection, an immuno- 
compromised state and a high infection load may 
promote easier detection than low infection state or 
successful antibiotic therapy. We can probably achieve 
higher sensitivity if whole blood samples are tested 
instead of serum samples and if the samples are tested 
as soon as they are received [7]. The examination of 
serum and blood samples taken at the very early stages 
of the disease, before the fifth day, may also be helpful 
for this purpose. 
Two of the 24 serum samples gave false-positive 
results by PCR,  as they did not hybridize with the 
product-specific DNA probe. However, we cannot 
exclude the possibility that this lack of hybridization 
might be a result of variations in the sequence of the 
amplified genomic fkagment. Two samples that appeared 
negative after electrophoresis hybridized with the same 
probe. Probably the PCR product of the last two 
samples was present in smaller amounts than the 
electrophoresis can detect; the detection ability of 
hybridization is known to be much higher than that of 
electrophoresis [ l l ] .  This might explain why the last 
two samples were negative by electrophoresis but 
positive by hybridization. Thus hybridization of the 
PCR products should follow in order to improve the 
specificity and the sensitivity. 
The 10 serum samples obtained from patients with 
no clinical symptoms of pneumonia and the 10 serum 
samples obtained from patients suffering from other 
atypical pneumonias were negative after PCR,  by 
both electrophoresis and hybridization tests. Thus the 
specificity of the P C R  is quite satisfactory despite the 
relatively low number of examined serum samples. 
The results of this study suggest that PCR could 
be applied to serum samples for the diagnosis of 
Legionnaires’ disease. For better evaluation of the 
method, a greater number of serum samples from 
proven cases of legionellosis should be examined. The 
follow-up of new patients with serum samples obtained 
on a daily basis may help to determine the days of illness 
on which the method has its best diagnostic value and 
may contribute to a better understanding of the 
pathogenesis of the disease. 
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